Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain
| Errataetall: |
CommentOn: JAMA Psychiatry. 2017 Jul 1;74(7):719-728. - PMID 28601891 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
JAMA psychiatry - 74(2017), 11 vom: 01. Nov., Seite 1172-1173 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Deutch, Ariel Y [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
839I73S42A |
|---|
| Anmerkungen: |
Date Completed 12.02.2019 Date Revised 15.02.2019 published: Print CommentOn: JAMA Psychiatry. 2017 Jul 1;74(7):719-728. - PMID 28601891 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jamapsychiatry.2017.3053 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM276427645 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM276427645 | ||
| 003 | DE-627 | ||
| 005 | 20231225012000.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamapsychiatry.2017.3053 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0921.xml |
| 035 | |a (DE-627)NLM276427645 | ||
| 035 | |a (NLM)28973118 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Deutch, Ariel Y |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.02.2019 | ||
| 500 | |a Date Revised 15.02.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: JAMA Psychiatry. 2017 Jul 1;74(7):719-728. - PMID 28601891 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 650 | 7 | |a Liraglutide |2 NLM | |
| 650 | 7 | |a 839I73S42A |2 NLM | |
| 650 | 7 | |a Clozapine |2 NLM | |
| 650 | 7 | |a J60AR2IKIC |2 NLM | |
| 650 | 7 | |a Olanzapine |2 NLM | |
| 650 | 7 | |a N7U69T4SZR |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA psychiatry |d 2013 |g 74(2017), 11 vom: 01. Nov., Seite 1172-1173 |w (DE-627)NLM22071942X |x 2168-6238 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2017 |g number:11 |g day:01 |g month:11 |g pages:1172-1173 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamapsychiatry.2017.3053 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2017 |e 11 |b 01 |c 11 |h 1172-1173 | ||